Dr. Jinxiang Fu
My Social Links

Dr. Jinxiang Fu

Professor
The Second Hospital of Soochow University, China

Highest Degree
Ph.D. in Immunology from Soochow University, Jiangsu, China

Share this Profile

Area of Interest:

Medicine
100%
Internal Medicine
62%
Medical Sciences
90%
Immunology
75%
Hematology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Tang, M., L. Xue, Y. Shen, L. Bo and R. Yang et al., 2018. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients. Clin. Rheumatol., 37: 245-250.
    CrossRef  |  Direct Link  |  
  2. Zhou, D.M., Y.X. Xu, L.Y. Zhang, Y. Sun, Z.Y. Wang, Y.Q. Yuan and J.X. Fu, 2017. The role of follicular T helper cells in patients with malignant lymphoid disease. Hematology, 22: 412-418.
    CrossRef  |  Direct Link  |  
  3. Yang, R., Y. Zhang, L. Wang, J. Hu and J. Wen et al., 2017. Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis. Oncotarget, 8: 15420-15430.
    CrossRef  |  Direct Link  |  
  4. Fu, J., 2017. Cx43 expressed on bone marrow stromal cells plays an essential role in multiple myeloma cell survival and drug resistance. Arch. Med. Sci., 13: 236-245.
    CrossRef  |  Direct Link  |  
  5. Zhang, L.Y., Y.Q. Yuan, D.M. Zhou, Z.Y. Wang and S.G. Ju et al., 2016. Impact of global and gene-specific DNA methylation in de novo or relapsed acute myeloid leukemia patients treated with decitabine. Asian Pac. J. Cancer Prev., 17: 431-437.
    PubMed  |  Direct Link  |  
  6. Wang, B., H. Yang, L. Shen, J. Wang and W. Pu et al., 2016. Rs56288038 (C/G) in 3'UTR of IRF-1 regulated by MiR-502-5p promotes gastric cancer development. Cell. Physiol. Biochem., 40: 391-399.
    CrossRef  |  Direct Link  |  
  7. Zhang, X., Y. Sun, Z. Wang, Z. Huang, B. Li and J. Fu, 2015. Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells. Leukemia Lymphoma, 56: 211-218.
    CrossRef  |  Direct Link  |  
  8. Li, B., J. Fu, P. Chen, X. Ge and Y. Li et al., 2015. The nuclear factor (erythroid-derived 2)-like 2 and proteasome maturation protein axis mediate bortezomib resistance in multiple myeloma. J. Biol. Chem., 290: 29854-29868.
    CrossRef  |  Direct Link  |  
  9. Rui, M., Z. Huang, Y. Liu, Z. Wang, R. Liu, J. Fu and H. Huang, 2014. Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression. Mol. Med. Rep., 10: 2137-2143.
    CrossRef  |  Direct Link  |  
  10. Li, Y., J. Li, W. Zhuang, Q. Wang and X. Ge et al., 2014. Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitro. Leukemia Res., 38: 970-976.
    CrossRef  |  Direct Link  |  
  11. Li, B., P. Chen, J. Qu, L. Shi and W. Zhuang et al., 2014. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J. Biol. Chem., 289: 29365-29375.
    CrossRef  |  Direct Link  |  
  12. Li, B., J. Fu, P. Chen and W. Zhuang, 2010. Impairment in immunomodulatory function of mesenchymal stem cells from multiple myeloma patients. Arch. Med. Res., 41: 623-633.
    CrossRef  |  Direct Link  |  
  13. Fu, J., P. Wang, X. Zhang, S. Ju and J. Li et al., 2010. Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis. Arch. Med. Sci., 6: 496-504.
    CrossRef  |  Direct Link  |  
  14. Chen, P., B. Li, W. Zhuang, H. Huang, H. Zhang and J. Fu, 2010. Multiple bone lesions and hypercalcemia presented in diffuse large B cell lymphoma: Mimicking multiple myeloma? Int. J. Hematol., 91: 716-722.
    CrossRef  |  Direct Link  |  
  15. Huang, H., D. Wu, J. Fu, G. Chen and W. Chang et al., 2009. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells. Eur. J. Haematol., 83: 191-202.
    CrossRef  |  Direct Link  |  
  16. Huang, H., D. Wu, J. Fu and G. Chen, 2009. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid. Leukemia Lymphoma, 50: 966-973.
    CrossRef  |  Direct Link  |  
  17. Fu, J., X. Zhang, Y. Zhang, J. Zhang, P. Chen, J. Li and Y. Sun, 2009. SDF1/CXCR4 signalling promotes mobility of myeloma cells by activation and redistribution of cell surface adhesion molecules. Arch. Med. Sci., 5: 141-148.
    Direct Link  |  
  18. Fu, J., J. Zhang, X. Zhang and Y. Sun, 2008. Upregulated expression of RANKL on bone marrow stromal cells can stimulate osteoclast precursors to mature into functional osteoclasts and promote survival of myeloma cells. Arch. Med. Sci., 4: 233-241.
    Direct Link  |  
  19. Li, W., J. Fu, Y. Wang, W. Li, W. Shi and X. Zhang, 2005. Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia. Int. Immunol., 17: 429-437.
    CrossRef  |  Direct Link  |  
  20. Li, W., J. Fu, F. Wang, G. Yu, Y. Wang and X. Zhang, 2004. Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia. Cell. Mol. Immunol., 1: 142-147.
    PubMed  |  Direct Link  |  
  21. Fu, J.X., X. Shi, J.C. Qin, Y. Ge and X.G. Zhang, 2004. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro. Exp. Hematol., 32: 1204-1211.
    CrossRef  |  Direct Link  |